Preclinical assessment of stem cell therapies for neurological diseases

ILAR Journal

Volumn 51, Issue 1, 2010, Pages 24-41

  Joers, Valerie L ^a   Emborg, Marina E ^b  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cell based therapies; Grafting; Multiple sclerosis; Neurodegeneration; Nonhuman primate (NHP); Parkinson's disease; Preclinical evaluation; Stem cells; Stroke; Transplantation

Indexed keywords

EID: 77955755766     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.51.1.24     Document Type: Review

References (207)

1. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, Breakefield XO, Snyder EY. 2000. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc Natl Acad Sci U S A 97:12846-12851.
2. Aharonowiz M, Einstein O, Fainstein N, Lassmann H, Reubinoff B, Ben-Hur T. 2008. Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. PLoS One 3:e3145.
3. Andersson E, Tryggvason U, Deng Q, Friling S, Alekseenko Z, Robert B, Perlmann T, Ericson J. 2006. Identification of intrinsic determinants of midbrain dopamine neurons. Cell 124:393-405.
4. Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD, Miller RH. 2009. Human bone marrow-derived mesenchymal stem cells induce th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 57:1192-1203.
5. Bakay RA, Fiandaca MS, Barrow DL, Schiff A, Collins DC. 1985. Preliminary report on the use of fetal tissue transplantation to correct MPTPinduced parkinsonian-like syndrome in primates. Appl Neurophysiol 48:358-361.
6. Bang OY, Lee JS, Lee PH, Lee G. 2005. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57:874-882.
7. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R. 2002. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42-48.
8. Behrstock S, Ebert A, McHugh J, Vosberg S, Moore J, Schneider B, Capowski E, Hei D, Kordower J, Aebischer P, Svensen C. 2006. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. Gene Ther 13:379-388.
9. Behrstock S, Ebert AD, Klein S, Schmitt M, Moore JM, Svendsen CN. 2008. Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF. Cell Transplant 17:753-762.
10. Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD. 1996. Middle cerebral artery occlusion in the rat by intraluminal suture: Neurological and pathological evaluation of an improved model. Stroke 27:1616-1622; discussion 1623.
11. Ben-Hur T, Einstein O. 2006. Cell transplantation for diseases of myelin. In: Battler A, Leor J, eds. Stem Cell and Gene-based Therapy. London: Springer. p 75-96.
12. Ben-Hur T, Einstein O, Mizrachi-Kol R, Ben-Menachem O, Reinhartz E, Karussis D, Abramsky O. 2003. Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis. Glia 41:73-80.
13. Bezard E, Brotchie JM, Gross CE. 2001. Pathophysiology of levodopainduced dyskinesia: Potential for new therapies. Nat Rev Neurosci 2:577-588.
14. Bjorklund A, Stenevi U. 1979. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 177:555-560.
15. Bjorklund LM, Sanchez-Pernaute R, Chung S, Andersson T, Chen IY, McNaught KS, Brownell AL, Jenkins BG, Wahlestedt C, Kim KS, Isacson O. 2002. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 99:2344-2349.
16. Bjugstad KB, Redmond DE Jr, Teng YD, Elsworth JD, Roth RH, Blanchard BC, Snyder EY, Sladek JR Jr. 2005. Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: A return to control measures. Cell Transpl 14:183-192.
17. Bjugstad KB, Teng YD, Redmond DE Jr, Elsworth JD, Roth RH, Cornelius SK, Snyder EY, Sladek JR Jr. 2008. Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease. Exp Neurol 211:362-369.
18. Blandini F, Armentero MT, Martignoni E. 2008. The 6-hydroxydopamine model: News from the past. Parkinsonism Relat Disord 14 Suppl 2:S124-S129.
19. Borlongan CV. 2009. Cell therapy for stroke: Remaining issues to address before embarking on clinical trials. Stroke 40:S146-S148.
20. Borlongan CV, Tajima Y, Trojanowski JQ, Lee VM, Sanberg PR. 1998. Cerebral ischemia and CNS transplantation: Differential effects of grafted fetal rat striatal cells and human neurons derived from a clonal cell line. Neuroreport 9:3703-3709.
21. Borlongan CV, Hadman M, Sanberg CD, Sanberg PR. 2004. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 35:2385-2389.
22. Bossolasco P, Cova L, Calzarossa C, Rimoldi SG, Borsotti C, Deliliers GL, Silani V, Soligo D, Polli E. 2005. Neuro-glial differentiation of human bone marrow stem cells in vitro. Exp Neurol 193:312-325.
23. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. 2003. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211.
24. Branston NM, Symon L, Crockard HA, Pasztor E. 1974. Relationship between the cortical evoked potential and local cortical blood flow following acute middle cerebral artery occlusion in the baboon. Exp Neurol 45:195-208.
25. Brazelton TR, Rossi FM, Keshet GI, Blau HM. 2000. From marrow to brain: Expression of neuronal phenotypes in adult mice. Science 290:1775-1779.
26. Bremer AM, Watanabe O, Bourke RS. 1975. Artificial embolization of the middle cerebral artery in primates: Description of an experimental model with extracranial technique. Stroke 6:387-390.
27. Brok HP, Uccelli A, Kerlero De Rosbo N, Bontrop RE, Roccatagliata L, de Groot NG, Capello E, Laman JD, Nicolay K, Mancardi GL, Ben-Nun A, Hart BA. 2000. Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: The encephalitogenic T cell epitope pmog24-36 is presented by a monomorphic MHC class II molecule. J Immunol 165:1093-1101.
28. Brüstle O, Jones KN, Learish RD, Karram K, Choudhary K, Wiestler OD, Duncan ID, McKay RD. 1999. Embryonic stem cell-derived glial precursors:A source of myelinating transplants. Science 285:754-756.
29. Buchan AM, Xue D, Slivka A. 1992. A new model of temporary focal neocortical ischemia in the rat. Stroke 23:273-279.
30. Buhnemann C, Scholz A, Bernreuther C, Malik CY, Braun H, Schachner M, Reymann KG, Dihne M. 2006. Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats. Brain 129:3238-3248.
31. Burns TC, Verfaillie CM, Low WC. 2009. Stem cells for ischemic brain injury: A critical review. J Comp Neurol 515:125-144.
32. Burt RK, Cohen B, Rose J, Petersen F, Oyama Y, Stefoski D, Katsamakis G, Carrier E, Kozak T, Muraro PA, Martin R, Hintzen R, Slavin S, Karussis D, Haggiag S, Voltarelli JC, Ellison GW, Jovanovic B, Popat U, McGuirk J, Statkute L, Verda L, Haas J, Arnold R. 2005. Hematopoietic stem cell transplantation for multiple sclerosis. Arch Neurol 62:860-864.
33. Burt RK, Loh Y, Cohen B, Stefoski D, Balabanov R, Katsamakis G, Oyama Y, Russell EJ, Stern J, Muraro P, Rose J, Testori A, Bucha J, Jovanovic B, Milanetti F, Storek J, Voltarelli JC, Burns WH. 2009. Autologous nonmyeloablative haemopoietic stem cell transplantation in relapsingremitting multiple sclerosis: A phase I/II study. Lancet Neurol 8:244-253.
34. Buytaert-Hoefen KA, Alvarez E, Freed CR. 2004. Generation of tyrosine hydroxylase positive neurons from human embryonic stem cells after coculture with cellular substrates and exposure to GDNF. Stem Cells 22:669-674.
35. Cai J, Donaldson A, Yang M, German MS, Enikolopov G, Iacovitti L. 2009. The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model. Stem Cells 27:220-229.
36. Capitanio JP, Emborg ME. 2008. Contributions of non-human primates to neuroscience research. Lancet 371:1126-1135.
37. Cenci MA. 2007. L-dopa-induced dyskinesia: Cellular mechanisms and approaches to treatment. Parkinsonism Relat Disord 13 Suppl 3:S263-S267.
38. Chamberlain SJ, Li XJ, Lalande M. 2008. Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders. Neurogenetics 9:227-235.
39. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, Chopp M. 2001a. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32:1005-1011.
40. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M. 2001b. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32:2682-2688.
41. Cho MS, Lee YE, Kim JY, Chung S, Cho YH, Kim DS, Kang SM, Lee H, Kim MH, Kim JH, Leem JW, Oh SK, Choi YM, Hwang DY, Chang JW, Kim DW. 2008. Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A 105:3392-3397.
42. Courtney AM, Treadaway K, Remington G, Frohman E. 2009. Multiple sclerosis. Med Clin North Am 93:451-476.
43. Crowell RM, Olsson Y, Klatzo I, Ommaya A. 1970. Temporary occlusion of the middle cerebral artery in the monkey: Clinical and pathological observations. Stroke 1:439-448.
44. Crowell RM, Marcoux FW, DeGirolami U. 1981. Variability and reversibility of focal cerebral ischemia in unanesthetized monkeys. Neurology 31:1295-1302.
45. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM. 2002. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843.
46. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, Eggan K. 2008. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321: 1218-1221.
47. Donnan GA, Fisher M, Macleod M, Davis SM. 2008. Stroke. Lancet 371:1612-1623.
48. Durukan A, Tatlisumak T. 2007. Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 87:179-197.
49. Dziewczapolski G, Lie DC, Ray J, Gage FH, Shults CW. 2003. Survival and differentiation of adult rat-derived neural progenitor cells transplanted to the striatum of hemiparkinsonian rats. Exp Neurol 183:653-664.
50. Ebert A, Beres A, Barber A, Svensen C. 2008. Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease. Exp Neurol 209:213-223.
51. Ebert AD, Yu J, Rose FF Jr, Mattis VB, Lorson CL, Thomson JA, Svendsen CN. 2009. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457:277-280.
52. Einstein O, Karussis D, Grigoriadis N, Mizrachi-Kol R, Reinhartz E, Abramsky O, Ben-Hur T. 2003. Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis. Mol Cell Neurosci 24:1074-1082.
53. Einstein O, Grigoriadis N, Mizrachi-Kol R, Reinhartz E, Polyzoidou E, Lavon I, Milonas I, Karussis D, Abramsky O, Ben-Hur T. 2006. Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis. Exp Neurol 198:275-284.
54. Elsayed MH, Hogan TP, Shaw PL, Castro AJ. 1996. Use of fetal cortical grafts in hypoxic-ischemic brain injury in neonatal rats. Exp Neurol 137:127-141.
55. Emborg ME. 2004. Evaluation of animal models of Parkinson's disease for neuroprotective strategies. J Neurosci Methods 139:121-143.
56. Emborg ME. 2007. Nonhuman primate models of Parkinson's disease. ILAR J 48:337-349.
57. Emborg ME, Ebert AD, Moirano J, Peng S, Suzuki M, Capowski E, Joers V, Roitberg BZ, Aebischer P, Svendsen CN. 2008. GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2 expression in MPTP-treated cynomolgus moneys. Cell Transplant 17:383-395.
58. Erdo F, Buhrle C, Blunk J, Hoehn M, Xia Y, Fleischmann B, Focking M, Kustermann E, Kolossov E, Hescheler J, Hossmann KA, Trapp T. 2003. Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab 23:780-785.
59. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nodborg C, Peterson DA, Gage FH. 1998. Neurogenesis in the adult human hippocampus. Nat Med 4:1313-1317.
60. Fallahi-Sichani M, Soleimani M, Najafi SMA, Kiani J, Arefian E, Atashi A. 2007. In vitro differentiation of cord blood unrestricted somatic stem cells expressing-associated genes into neuron-like cells. Cell Bio Internat 31:299-307.
61. Fassas A, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T, Havrdova E, Carreras E, Graus F, Kashyap A, Openshaw H, Schipperus M, Deconinck E, Mancardi G, Marmont A, Hansz J, Rabusin M, Zuazu Nagore FJ, Besalduch J, Dentamaro T, Fouillard L, Hertenstein B, La Nasa G, Musso M, Papineschi F, Rowe JM, Saccardi R, Steck A, Kappos L, Gratwohl A, Tyndall A, Samijn J. 2002. Hematopoietic stem cell transplantation for multiple sclerosis: A retrospective multicenter study. J Neurol 249:1088-1097.
62. Fitzpatrick K, Raschke J, Emborg M. 2009. Cell-based therapies for Parkinson's disease: Past, present and future. Antioxid Redox Signal [Epub ahead of print]. Flachenecker P, Stuke K. 2008. National MS registries. J Neurol 255 Suppl 6:102-108.
63. Frazee JG, Luo X, Luan G, Hinton DS, Hovda DA, Shiroishi MS, Barcliff LT. 1998. Retrograde transvenous neuroperfusion: A back door treatment for stroke. Stroke 29:1912-1916.
64. Fukuchi K, Kusuoka H, Watanabe Y, Nishimura T. 1999. Correlation of sequential MR images of microsphere-induced cerebral ischemia with histologic changes in rats. Invest Radiol 34:698-703.
65. Gage FH, Coates PW, Palmer TD, Kuhn HG, Fisher LJ, Suhonen JO, Peterson DA, Suhr ST, Ray J. 1995. Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci U S A 92:11879-11883.
66. Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins F, Hoffer BJ, Gerhardt GA. 1996. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380:252-255.
67. Gawrylewski A. 2007. The trouble with animal models. Scientist 21:44-51.
68. Genain CP, Nguyen MH, Letvin NL, Pearl R, Davis RL, Adelman M, Lees MB, Linington C, Hauser SL. 1995. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest 96:2966-2974.
69. Genain CP, Abel K, Belmar N, Villinger F, Rosenberg DP, Linington C, Raine CS, Hauser SL. 1996. Late complications of immune deviation therapy in a nonhuman primate. Science 274:2054-2057.
70. Gerdoni E, Gallo B, Casazza S, Musio S, Bonanni I, Pedemonte E, Mantegazza R, Frassoni F, Mancardi G, Pedotti R, Uccelli A. 2007. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 61:219-227.
71. Giordano A, Galderisi U, Marino IR. 2007. From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells. J Cell Physiol 211:27-35.
72. Gold R, Linington C, Lassmann H. 2006. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129:1953-1971.
73. Gould E, Reeves AJ, Graziano MS, Gross CG. 1999. Neurogenesis in the neocortex of adult primates. Science 286:548-552.
74. Grabowski M, Brundin P, Johansson BB. 1992. Fetal neocortical grafts implanted in adult hypertensive rats with cortical infarcts following a middle cerebral artery occlusion: Ingrowth of afferent fibers from the host brain. Exp Neurol 116:105-121.
75. Grabowski M, Brundin P, Johansson BB. 1993. Functional integration of cortical grafts placed in brain infarcts of rats. Ann Neurol 34:362-368.
76. Gregory C. 2008. Mesenchymal stem cells: From culture to clinic. In: Levicar N, Habib NA, Gordon MY, Dimarakis I. Stem Cell Repair and Regeneration, vol 3. London: Imperial College Press. p 21-43.
77. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D. 2008. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317-1329.
78. Halme DG, Kessler DA. 2006. FDA regulation of stem-cell-based therapies. N Engl J Med 355:1730-1735.
79. Hatano S. 1976. Experience from a multicentre stroke register: A preliminary report. Bull World Health Organ 54:541-553.
80. Hayashi J, Takagi Y, Fukuda H, Imazato T, Nishimura M, Fujimoto M, Takahashi J, Hashimoto N, Nozaki K. 2006. Primate embryonic stem cell-derived neuronal progenitors transplanted into ischemic brain. J Cereb Blood Flow Metab 26:906-914.
81. Hedlund E, Pruszak J, Lardaro T, Ludwig W, Vinuela A, Kin K-S, Isacson O. 2008. Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells 26:1526-1536.
82. Hida N, Nishiyama N, Miyoshi S, Kira S, Segawa K, Uyama T, Mori T, Miyado K, Ikegami Y, Cui C, Kiyono T, Kyo S, Shimizu T, Okano T, Sakamoto M, Ogawa S, Umezawa A. 2008. Novel cardiac precursorlike cells from human menstrual blood-derived mesenchymal cells. Stem Cells 26:1695-1704.
83. Higgins P, Lees KR. 2009. Advances in emerging therapies. Stroke 40:e292-e294.
84. Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T, Wecker S, Focking M, Arnold H, Hescheler J, Fleischmann BK, Schwindt W, Buhrle C. 2002. Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 99:16267-16272.
85. Honma T, Honmou O, Iihoshi S, Harada K, Houkin K, Hamada H, Kocsis JD. 2006. Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp Neurol 199:56-66.
86. Hudgins WR, Garcia JH. 1970. Transorbital approach to the middle cerebral artery of the squirrel monkey: A technique for experimental cerebral infarction applicable to ultrastructural studies. Stroke 1:107-111.
87. Hurlbut WB. 2005. Altered nuclear transfer: A way forward for embryonic stem cell research. Stem Cell Rev 1:293-300.
88. Izrael M, Zhang P, Kaufman R, Shinder V, Ella R, Amit M, Itskovitz-Eldor J, Chebath J, Revel M. 2007. Human oligodendrocytes derived from embryonic stem cells: Effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. Mol Cell Neurosci 34:310-323.
89. Jansen EM, Solberg L, Underhill S, Wilson S, Cozzari C, Hartman BK, Faris PL, Low WC. 1997. Transplantation of fetal neocortex ameliorates sensorimotor and locomotor deficits following neonatal ischemichypoxic brain injury in rats. Exp Neurol 147:487-497.
90. Jeong SW, Chu K, Jung KH, Kim SU, Kim M, Roh JK. 2003. Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke 34:2258-2263.
91. Kaneko D, Nakamura N, Ogawa T. 1985. Cerebral infarction in rats using homologous blood emboli: Development of a new experimental model. Stroke 16:76-84.
92. Karussis D, Kassis I. 2008. The potential use of stem cells in multiple sclerosis: An overview of the preclinical experience. Clin Neurol Neurosurg 110:889-896.
93. Karussis DM, Vourka-Karussis U, Lehmann D, Ovadia H, Mizrachi-Koll R, Ben-Nun A, Abramsky O, Slavin S. 1993. Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation. J Clin Invest 92:765-772.
94. Karussis D, Kassis I, Kurkalli BG, Slavin S. 2008. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): A proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. J Neurol Sci 265:131-135.
95. Kassis I, Grigoriadis N, Gowda-Kurkalli B, Mizrachi-Kol R, Ben-Hur T, Slavin S, Abramsky O, Karussis D. 2008. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 65:753-761.
96. Kastenberg ZJ, Odorico JS. 2008. Alternative sources of pluripotency: Science, ethics, and stem cells. Transplant Rev 22:215-222.
97. Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S, Nishikawa SI, Sasai Y. 2000. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28:31-40.
98. Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K, Steward O. 2005. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25:4694-4705.
99. Kelly S, Bliss TM, Shah AK, Sun GH, Ma M, Foo WC, Masel J, Yenari MA, Weissman IL, Uchida N, Palmer T, Steinberg GK. 2004. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A 101:11839-11844.
100. Kim JH, Auerbach JM, Rodriguez-Gomez JA, Velasco I, Gavin D, Lumelsky N, Lee SH, Nguyen J, Sanchez-Pernaute R, Bankiewicz K, McKay R. 2002. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418:50-56.
101. Kimmelman J, London AJ, Ravina B, Ramsay T, Bernstein M, Fine A, Stahnisch FW, Emborg ME. 2009. Launching invasive, first-in-human trials against Parkinson's disease: Ethical considerations. Mov Disord 24:1893-1901.
102. Kleppner SR, Robinson KA, Trojanowski JQ, Lee VM. 1995. Transplanted human neurons derived from a teratocarcinoma cell line (ntera-2) mature, integrate, and survive for over 1 year in the nude mouse brain. J Comp Neurol 357:618-632.
103. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. 1986. Experimental studies of ischemic brain edema: 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 8:1-8.
104. Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn KR, Gebel J, Jannetta P, DeCesare S, Elder EM, McGrogan M, Reitman MA, Bynum L. 2000. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55:565-569.
105. Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, Gebel J, Decesare S, Jovin T, Zafonte R, Lebowitz J, Flickinger JC, Tong D, Marks MP, Jamieson C, Luu D, Bell-Stephens T, Teraoka J. 2005. Neurotransplantation for patients with subcortical motor stroke: A phase 2 randomized trial. J Neurosurg 103:38-45.
106. Kopen GC, Prockop DJ, Phinney DG. 1999. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 96:10711-10716.
107. Korell M, Tanner C. 2005. Epidemiology of Parkinson's disease: An overview. In: Ebadi M, Pfeiffer R, eds. Parkinson's Disease. Boca Raton: CRC Press. p 39-50.
108. Kudo M, Aoyama A, Ichimori S, Fukunaga N. 1982. An animal model of cerebral infarction: Homologous blood clot emboli in rats. Stroke 13: 505-508.
109. Kumar A, Huang Z, Calne D. 2005. Parkinson's disease: Where are we? In: Ebadi M, Pfeiffer R, eds. Parkinson's Disease. Boca Raton: CRC Press. p 27-38.
110. Langston JW. 2006. The Parkinson's complex: Parkinsonism is just the tip of the iceberg. Annals Neurol 59:591-596.
111. Levy YS, Bahat-Stroomza M, Barzilay R, Burshtein A, Bulvik S, Barhum Y, Panet H, Melamed E, Offen D. 2008. Regenerative effect of neuralinduced human mesenchymal stromal cells in rat models of Parkinson's disease. Cytotherapy 10:340-352.
112. Li Y, Chopp M, Chen J, Wang L, Gautam SC, Xu YX, Zhang Z. 2000. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 20:1311-1319.
113. Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, Katakowski M, Zhang LJ, Lu M, Janakiraman N, Chopp M. 2002. Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery. Neurology 59:514-523.
114. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. 1993. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132.
115. Lindvall O, Kokaia Z. 2009. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci 30:260-267.
116. Liu H, Zhu F, Yong J, Zhang P, Hou P, Li H, Jiang W, Cai J, Liu M, Cui K, Qu X, Xiang T, Lu D, Gao G, Ji W, Ding M, Deng H. 2008. Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell 3:587-590.
117. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y. 2009. Heart disease and stroke statistics--2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119:480-486.
118. Longa EZ, Weinstein PR, Carlson S, Cummins R. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91.
119. Mancardi G, Saccardi R. 2008. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol 7:626-636.
120. Massacesi L, Genain CP, Lee-Parritz D, Letvin NL, Canfield D, Hauser SL. 1995. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: A new model for multiple sclerosis. Ann Neurol 37:519-530.
121. McCoy MK, Martinez TN, Ruhn KA, Wrage PC, Keefer EW, Botterman BR, Tansey KE. 2008. Autologous transplants of adipose-derived adult stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease. Exp Neurol 210:14-29.
122. Meng X, Ichim TE, Zhong J, Rogers A, Yin Z, Jackson J, Wang H, Ge W, Bogin V, Chan KW, Thebaud B, Riordan NH. 2007. Endometrial regenerative cells: A novel stem cell population. J Transl Med 5:57.
123. Mix E, Meyer-Rienecker H, Zettl UK. 2008. Animal models of multiple sclerosis for the development and validation of novel therapies: Potential and limitations. J Neurol 255 Suppl 6:7-14.
124. Murphy MP, Wang H, Patel AN, Kambhampati S, Angle N, Chan K, Marleau AM, Pyszniak A, Carrier E, Ichim TE, Riordan NH. 2008. Allogeneic endometrial regenerative cells: An "off the shelf solution" for critical limb ischemia? J Transl Med 6:45.
125. Newcomb JD, Sanberg PR, Klasko SK, Willing AE. 2007. Umbilical cord blood research: Current and future perspectives. Cell Transpl 16:151-158.
126. Newman MB, Willing AE, Manresa JJ, Davis-Sanberg C, Sanberg PR. 2005. Stroke-induced migration of human umbilical cord blood cells: Time course and cytokines. Stem Cells Dev 14:576-586.
127. Nishino H, Hida H, Takei N, Kumazaki M, Nakajima K, Baba H. 2000. Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum. Exp Neurol 164:209-214.
128. Nistor GI, Totoiu MO, Haque N, Carpenter MK, Keirstead HS. 2005. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49:385-396.
129. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. 2000. Multiple sclerosis. N Engl J Med 343:938-952.
130. O'Keeffe FE, Scott SA, Tyers P, O'Keeffe GW, Dalley JW, Zufferey R, Caldwell MA. 2008. Induction of a9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease. Brain 131:630-641.
131. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. 2008. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-953.
132. Papadopoulos SM, Chandler WF, Salamat MS, Topol EJ, Sackellares JC. 1987. Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke. J Neurosurg 67:394-398.
133. Parish CL, Castelo-Branco G, Rawal N, Tonnesen J, Sorensen AT, Salto C, Kokaia M, Lindvall O, Arenas E. 2008. Wnt5a-treated midbrain neuralstem cells improve dopamine cell replacement therapy in parkinsonian mice. J Clin Invest 118:149-160.
134. Park DH, Borlongan CV, Willing AE, Eve DJ, Sanberg PR. 2009. Human umbilical cord blood cell grafts for stroke. Cell Transpl [Epub ahead of print].
135. Perrier AL, Tabar V, Barberi T, Rubio ME, Bruses J, Topf N, Harrison NL, Studer L. 2004. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A 101:12543-12548.
136. Pleasure SJ, Page C, Lee VM. 1992. Pure, postmitotic, polarized human neurons derived from ntera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 12: 1802-1815.
137. Pluchino S, Quattrini A, Brambilla E, Gritti A, Salani G, Dina G, Galli R, Del Carro U, Amadio S, Bergami A, Furlan R, Comi G, Vescovi AL, Martino G. 2003. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422:688-694.
138. Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akram M. 2001. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP): A technical review of its utility and safety. J Neurochem 76:1265-1274.
139. Qu T, Brannen CL, Kim HM, Sugaya K. 2001. Human neural stem cells improve cognitive function of aged brain. Neuroreport 12:1127-1132.
140. Rakic P. 2004. Immigration denied. Nature 427:685-686.
141. Redmond DE Jr, Sladek JR Jr, Roth RH, Collier TJ, Elsworth JD, Deutch AY, Haber S. 1986. Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet 1:1125-1127.
142. Redmond DE Jr, Bjugstad KB, Teng YD, Ourednik J, Wakeman DR, Parsons XH, Gonzalez R, Blanchard BC, Kim SU, Gu Z, Lipton SA, Markakis EA, Roth RH, Elsworth JD, Sladek JR Jr, Sidman RL, Snyder EY. 2007. Behavioral improvement in a primate model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci U S A 104:12175-12180.
143. Robinson RG, Shoemaker WJ, Schlumpf M, Valk T, Bloom FE. 1975. Effect of experimental cerebral infarction in rat brain on catecholamines and behaviour. Nature 255:332-334.
144. Roccatagliata L, Rocca M, Valsasina P, Bonzano L, Sormani M, Saccardi R, Mancardi G, Filippi M. 2007. The long-term effect of AHSCT on MRI measures of MS evolution: A five-year follow-up study. Mult Scler 13: 1068-1070.
145. Rodriguez-Gomez JA, Lu JQ, Velasco I, Rivera S, Zoghbi SS, Liow JS, Musachio JL, Chin FT, Toyama H, Seidel J, Green MV, Thanos PK, Ichise M, Pike VW, Innis RB, McKay RD. 2007. Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 25:918-928.
146. Roitberg B, Khan N, Tuccar E, Kompoliti K, Chu Y, Alperin N, Kordower JH, Emborg ME. 2003. Chronic ischemic stroke model in cynomolgus monkeys: Behavioral, neuroimaging and anatomical study. Neurol Res 25:68-78.
147. Roitberg BZ, Mangubat E, Chen EY, Sugaya K, Thulborn KR, Kordower JH, Pawar A, Konecny T, Emborg ME. 2006. Survival and early differentiation of human neural stem cells transplanted in a nonhuman primate model of stroke. J Neurosurg 105:96-102.
148. Roy NS, Cleren C, Singh SK, Yang L, Beal MF, Goldman SA. 2006. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 12:1259-1268.
149. Sanai N, Tramontin AD, Quinones-Hinojosa A, Barbaro NM Gupta N, Kunwar S, Lawton MT, McDermott MW, Parsa AT, Manuel-Garcia Verdugo J, Berger MS, Alvarez-Buylla A. 2004. Unique astrocyte ribbon I adult human brain contains neural stem cells but lacks chain migration. Nature 427:740-744.
150. Sanchez-Pernaute R, Studer L, Bankiewicz KS, Major EO, McKay RD. 2001. In vitro generation and transplantation of precursor-derived human dopamine neurons. J Neurosci Res 65:284-288.
151. Sanchez-Pernaute R, Studer L, Ferrari D, Perrier A, Lee H, Vinuela A, Isacson O. 2005. Long-term survival of dopaminergic neurons derived from parthenogenetic primate embryonic stem cells (cyno-1) after transplantation. Stem Cells 23:914-922.
152. Sanchez-Ramos JR, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR, Sanberg PR. 2000. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164:247-256.
153. Sanchez-Ramos JR, Song S, Kamath SG, Zigova T, Willing A, Cardozo-Pelaez F, Stedeford T, Chopp M, Sanberg PR. 2001. Expression of neural markers in human umbilical cord blood. Exp Neurol 171: 109-115.
154. Saporta S, Borlongan CV, Sanberg PR. 1999. Neural transplantation of human neuroteratocarcinoma (hnt) neurons into ischemic rats: A quantitative dose-response analysis of cell survival and behavioral recovery. Neuroscience 91:519-525.
155. Savitz SI, Rosenbaum DM, Dinsmore JH, Wechsler LR, Caplan LR. 2002. Cell transplantation for stroke. Ann Neurol 52:266-275.
156. Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR. 2005. Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: A preliminary safety and feasibility study. Cerebrovasc Dis 20:101-107.
157. Sayeed I, Wali B, Stein DG. 2007. Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Restor Neurol Neurosci 25:151-159.
158. Schaffler A, Buchler C. 2007. Concise review: Adipose tissue-derived stromal cells: Basic and clinical implications for novel cell-based therapies. Stem Cells 25:818-827.
159. Shigeno T, Teasdale GM, McCulloch J, Graham DI. 1985. Recirculation model following MCA occlusion in rats: Cerebral blood flow, cerebrovascular permeability, and brain edema. J Neurosurg 63:272-277.
160. Shim JW, Park CH, Bae YC, Bae JY, Chung S, Chang MY, Koh HC, Lee HS, Hwang SJ, Lee KH, Lee YS, Choi CY, Lee SH. 2007. Generation of functional dopamine neurons from neural precursor cells isolated from the subventricular zone and white matter of the adult rat brain using nurr1 overexpression. Stem Cells 25:1252-1262.
161. Shindo T, Matsumoto Y, Wang Q, Kawai N, Tamiya T, Nagao S. 2006. Differences in the neuronal stem cells survival, neuronal differentiation and neurological improvement after transplantation of neural stem cells between mild and severe experimental traumatic brain injury. J Med Invest 53:42-51.
162. Siegel BA, Meidinger R, Elliott AJ, Studer R, Curtis C, Morgan J, Potchen EJ. 1972. Experimental cerebral microembolism: Multiple tracer assessment of brain edema. Arch Neurol 26:73-77.
163. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, Isacson O, Jaenisch R. 2009. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136:964-977.
164. Spetzler RF, Selman WR, Weinstein P, Townsend J, Mehdorn M, Telles D, Crumrine RC, Macko R. 1980. Chronic reversible cerebral ischemia: Evaluation of a new baboon model. Neurosurgery 7:257-261
165. Stamm C, Ma N. 2008. Cord blood cells for myocardial regeneration. In: Levicar N, Habib NA, Gordon MY, Dimarakis I, eds. Stem Cell Repair and Regeneration, vol 3. London: Imperial College Press. p 129-146.
166. Studer L, Tabar V, McKay RD. 1998. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci 1:290-295.
167. Svendsen CN, Caldwell MA, Shen J, ter Borg MG, Rosser AE, Tyers P, Karmiol S, Dunnett SB. 1997. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. Exp Neurol 148:135-146.
168. Swanborg RH. 1995. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin Immunol Immunop 77:4-13.
169. Symon L. 1975. Experimental model of stroke in the baboon. Adv Neurol 10:199-212.
170. 't Hart BA, van Meurs M, Brok HP, Massacesi L, Bauer J, Boon L, Bontrop RE, Laman JD. 2000. A new primate model for multiple sclerosis in the common marmoset. Immunol Today 21:290-297.
171. Tabar V, Tomishima M, Panagiotakos G, Wakayama S, Menon J, Chan B, Mizutani E, Al-Shamy G, Ohta H, Wakayama T, Studer L. 2008. Therapeutic cloning in individual parkinsonian mice. Nat Med 14:379-381.
172. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H, Tsukamoto Y, Iso H, Fujimori Y, Stern DM, Naritomi H, Matsuyama T. 2004. Administration of cd34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 114:330-338.
173. Takagi Y, Takahashi J, Saiki H, Morizane A, Hayashi T, Kishi Y, Fukuda H, Okamoto Y, Koyanagi M, Ideguchi M, Hayashi H, Imazato T, Kawasaki H, Suemori H, Omachi S, Iida H, Itoh N, Nakatsuji N, Sasai Y, Hashimoto N. 2005. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson's primate model. J Clin Invest 115: 102-109.
174. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
175. Takahashi K, Okita K, Nakagawa M, Yamanaka S. 2007. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2:3081-3089.
176. Takeo S, Taguchi T, Tanonaka K, Miyake K, Horiguchi T, Takagi N, Fujimori K. 1992. Sustained damage to energy metabolism of brain regions after microsphere embolism in rats. Stroke 23:62-68.
177. Tamura A, Graham DI, McCulloch J, Teasdale GM. 1981. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1:53-60.
178. Thomson JA, Marshall VS. 1998. Primate embryonic stem cells. Curr Top Dev Biol 38:133-165.
179. Thomson JA, Kalishman J, Golos TG, Durning M, Harris CP, Becker RA, Hearn JP. 1995. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A 92:7844-7848.
180. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
181. Traystman RJ. 2003. Animal models of focal and global cerebral ischemia. ILAR J 44:85-95.
182. Tsukada T, Watanabe M, Yamashima T. 2001. Implications of CAD and DNAse II in ischemic neuronal necrosis specific for the primate hippocampus. J Neurochem 79:1196-1206.
183. Uccelli A, Giunti D, Capello E, Roccatagliata L, Mancardi GL. 2003. EAE in the common marmoset Callithrix jacchus. Int MS J 10:6-12.
184. van Gelder M, van Bekkum DW. 1996. Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation. Bone Marrow Transpl 18:1029-1034.
185. Vendrame M, Cassady J, Newcomb J, Butler T, Pennypacker KR, Zigova T, Sanberg CD, Sanberg PR, Willing AE. 2004. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 35:2390-2395.
186. Videnovic A, Metman LV. 2008. Deep brain stimulation for Parkinson's disease: Prevalence of adverse events and need for standardized reporting. Mov Disord 23:343-349.
187. Vora N, Jovin T, Kondziolka D. 2006. Cell transplantation for ischemic stroke. Neurodegener Dis 3:101-105.
188. Watanabe O, Bremer AM, West CR. 1977. Experimental regional cerebral ischemia in the middle cerebral artery territory in primates. Part 1: Angio-anatomy and description of an experimental model with selective embolization of the internal carotid artery bifurcation. Stroke 8:61-70.
189. Watts C, Dunnett SB. 1998. Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: Implications for timing of surgical intervention. J Neurosurg 89:267-274.
190. Wei L, Cui L, Snider BJ, Rivkin M, Yu SS, Lee CS, Adams LD, Gottlieb DI, Johnson EM Jr, Yu SP, Choi DW. 2005. Transplantation of embryonic stem cells overexpressing bcl-2 promotes functional recovery after transient cerebral ischemia. Neurobiol Dis 19:183-193.
191. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, Constantine-Paton M, Isacson O, Jaenisch R. 2008. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A 15:5856-5861.
192. West GA, Golshani KJ, Doyle KP, Lessov NS, Hobbs TR, Kohama SG, Pike MM, Kroenke CD, Grafe MR, Spector MD, Tobar ET, Simon RP, Stenzel-Poore MP. 2009. A new model of cortical stroke in the rhesus macaque. J Cereb Blood Flow Metab 29:1175-1186.
193. Westwood C, Clements MO. 2008. The biology of human mesenchymal stem cells. In: Levicar N, Habib NA, Gordon MY, Dimarakis I, eds. Stem Cell Repair and Regeneration, vol 3. London: Imperial College Press. p 1-20.
194. Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S, Hart C, Sanchez-Ramos J, Sanberg PR. 2003. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J Neurosci Res 73:296-307.
195. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. 1997. Viable offspring derived from fetal and adult mammalian cells. Nature 385:810-813.
196. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. 2000. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61:364-370.
197. Xiao J, Nan Z, Motooka Y, Low WC. 2005. Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells Dev 14:722-733.
198. Yamashima T, Saido TC, Takita M, Miyazawa A, Yamano J, Miyakawa A, Nishijyo H, Yamashita J, Kawashima S, Ono T, Yoshioka T. 1996. Transient brain ischaemia provokes ca2+, pip2 and calpain responses prior to delayed neuronal death in monkeys. Eur J Neurosci 8:1932-1944.
199. Yonas H, Gur D, Claassen D, Wolfson SK Jr, Moossy J. 1990. Stable xenonenhanced CT measurement of cerebral blood flow in reversible focal ischemia in baboons. J Neurosurg 73:266-273.
200. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
201. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F, Mancardi G, Uccelli A. 2005. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell energy. Blood 106:1755-1761.
202. Zeng X, Cai J, Chen J, Luo Y, You Z-B, Fotter E, Wang Y, Harvey B, Miura T, Backman C, Chen G-J, Rao MS, Freed WJ. 2004. Dopaminergic differentiation of human embryonic stem cells. Stem Cells 22:925-940.
203. Zhan X, Hill C, Brayton CF, Shamblott MJ. 2008. Cells derived from human umbilical cord blood support the long-term growth of undifferentiated human embryonic stem cells. Cloning and Stem Cells 10:513-522.
204. Zhang J, Li Y, Chen J, Cui Y, Lu M, Elias SB, Mitchell JB, Hammill L, Vanguri P, Chopp M. 2005. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 195:16-26.
205. Zhang Z, Zhang RL, Jiang Q, Raman SB, Cantwell L, Chopp M. 1997. A new rat model of thrombotic focal cerebral ischemia. J Cereb Blood Flow Metab 17:123-135.
206. Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC. 2002. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol 174:11-20.
207. Zhong Z, Patel AN, Ichim TE, Riordan NH, Wang H, Min WP, Woods EJ, Reid M, Mansilla E, Marin GH, Drago H, Murphy MP, Minev B. 2009. Feasibility investigation of allogeneic endometrial regenerative cells. J Transl Med 7:15.